Credit Suisse
"Credit Suisse rates A2M as Outperform
Wednesday, November 18, 2015 - 16:58
The company has raised its earnings guidance to NZ$22m, driven by higher sales in infant formula but partly offset by slower ramp up in US sales.
Credit Suisse observes the company is leveraging a successful Australian model into global opportunities and the first half result should provide confirmation of further traction in infant formula and an update on the liquid milk distribution in the US.
Outperform retained. Target is raised to NZ$1.18 from NZ$1.03.
Current Price is $0.88. Target price not assessed.
Current consensus price target is N/A
The company's fiscal year ends in June."
http://www.eurekareport.com.au/broker-alerts/all companies
UBS analyst says the A2 Milk..., page-15
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.99 |
Change
-0.120(1.69%) |
Mkt cap ! $5.053B | |||
| Open | High | Low | Value | Volume |
| $7.00 | $7.07 | $6.96 | $10.80M | 1.545M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 13394 | $6.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.99 | 4946 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| A2M (ASX) Chart |